|
FR580494A
(fr)
|
1923-07-10 |
1924-11-07 |
Const Metalliques Schiltigheim |
Procédé d'établissement des buses d'aération ou autres tuyaux
|
|
US3067197A
(en)
*
|
1961-04-26 |
1962-12-04 |
Pfizer & Co C |
11-oxygenated 6alpha-fluoro-16-methylene-delta-pregnenes and derivatives
|
|
US3639434A
(en)
*
|
1967-02-02 |
1972-02-01 |
Boots Pure Drug Co Ltd |
17-acyloxysteroids and their manufacture
|
|
GB1384372A
(en)
|
1971-01-20 |
1975-02-19 |
Glaxo Lab Ltd |
Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
|
|
US3828080A
(en)
*
|
1972-01-20 |
1974-08-06 |
Glaxo Lab Ltd |
Androstane-17beta-carboxylic acids and processes for the preparation thereof
|
|
US3989686A
(en)
*
|
1972-06-15 |
1976-11-02 |
Glaxo Laboratories Limited |
Anaesthetic steroids of the androstane series and process for preparing same
|
|
GB1438940A
(en)
*
|
1972-07-19 |
1976-06-09 |
Glaxo Lab Ltd |
17beta-haloalkoxycarbonyl-17alpha-oxysteroids
|
|
DE2338693A1
(de)
|
1973-07-31 |
1975-02-13 |
Schmude Kg H |
Verfahren zur herstellung von geschaeumten kunststoff-formteilen, die mit einer homogenen aussenhaut versehen sind
|
|
US4093721A
(en)
*
|
1974-08-30 |
1978-06-06 |
Glaxo Laboratories Limited |
Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
|
|
GB1517278A
(en)
|
1974-08-30 |
1978-07-12 |
Glaxo Lab Ltd |
Alkyl and haloalkyl androsta-1,4,15-triene and-4,15-diene-17beta-carboxylates
|
|
DE2538569A1
(de)
|
1975-08-29 |
1977-03-03 |
Siemens Ag |
Verfahren zur metallisierung von duroplasten
|
|
CH628355A5
(de)
*
|
1976-02-24 |
1982-02-26 |
Ciba Geigy Ag |
Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
|
|
US4187301A
(en)
*
|
1978-04-05 |
1980-02-05 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
|
|
US4198403A
(en)
|
1978-04-05 |
1980-04-15 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes
|
|
US4263289A
(en)
*
|
1978-04-05 |
1981-04-21 |
Syntex (U.S.A.) Inc. |
Thio etianic acid derivatives
|
|
US4188385A
(en)
*
|
1978-04-05 |
1980-02-12 |
Syntex (U.S.A.) Inc. |
Thioetianic acid derivatives
|
|
US4261984A
(en)
*
|
1978-04-05 |
1981-04-14 |
Syntex (U.S.A.) Inc. |
17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
|
|
DE2817988A1
(de)
*
|
1978-04-25 |
1979-11-08 |
Hoechst Ag |
Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
|
|
US4310466A
(en)
*
|
1979-08-31 |
1982-01-12 |
Syntex (U.S.A.) Inc. |
Thio etianic acid derivatives
|
|
US4267173A
(en)
*
|
1979-11-05 |
1981-05-12 |
Schering Corporation |
Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
|
|
US4335121A
(en)
|
1980-02-15 |
1982-06-15 |
Glaxo Group Limited |
Androstane carbothioates
|
|
US4996335A
(en)
*
|
1980-07-10 |
1991-02-26 |
Nicholas S. Bodor |
Soft steroids having anti-inflammatory activity
|
|
SE449106B
(sv)
|
1980-07-10 |
1987-04-06 |
Otsuka Pharma Co Ltd |
Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
|
|
US4710495A
(en)
*
|
1980-07-10 |
1987-12-01 |
Otsuka Pharmaceutical Co., Ltd. |
Soft steroids having anti-inflammatory activity
|
|
CY1359A
(en)
|
1981-02-02 |
1987-08-07 |
Schering Corp |
Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
|
|
ZW6584A1
(en)
*
|
1983-04-18 |
1985-04-17 |
Glaxo Group Ltd |
Phenethanolamine derivatives
|
|
US4607028A
(en)
*
|
1983-08-18 |
1986-08-19 |
Ciba-Geigy Corporation |
Novel carboxylic acid esters
|
|
CH664405A5
(de)
|
1983-09-01 |
1988-02-29 |
Plana Eng Ag |
Verfahren zur stabilisierung einer bodenschicht.
|
|
EP0179583A1
(en)
|
1984-10-04 |
1986-04-30 |
Merck & Co. Inc. |
A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
|
|
US4861765A
(en)
*
|
1985-06-26 |
1989-08-29 |
Jouveinal |
21-alkyl-, cycloalkyl- or aryl-substituted thio steroids and pharmaceutical compositions containing them
|
|
US4994439A
(en)
*
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
|
IL95590A
(en)
|
1989-09-08 |
1996-06-18 |
Glaxo Group Ltd |
Medicinal preparations containing Salmetrol and Pluticasone Propionate
|
|
DE3931041C2
(de)
|
1989-09-16 |
2000-04-06 |
Boehringer Ingelheim Kg |
Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
|
JP3087763B2
(ja)
|
1990-11-30 |
2000-09-11 |
三井化学株式会社 |
新規な複素環式化合物およびそれを含有する医薬組成物
|
|
GB9103764D0
(en)
|
1991-02-22 |
1991-04-10 |
Glaxo Group Ltd |
Compositions
|
|
US5250293A
(en)
*
|
1991-04-22 |
1993-10-05 |
Gleich Gerald J |
Method for the treatment of hypersensitivity diseases by administration of anionic polymers
|
|
TW247878B
(pt)
|
1991-07-02 |
1995-05-21 |
Takeda Pharm Industry Co Ltd |
|
|
US6127353A
(en)
|
1991-09-06 |
2000-10-03 |
Schering Corporation |
Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
|
|
US5658549A
(en)
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
|
CA2156408C
(en)
|
1993-03-17 |
2005-02-15 |
Daniel C. Duan |
Aerosol formulation containing a polyester dispersing aid
|
|
DE4328819A1
(de)
|
1993-08-27 |
1995-03-02 |
Hoechst Ag |
Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
|
DE4333920A1
(de)
|
1993-10-05 |
1995-04-13 |
Hoechst Ag |
Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
|
US5420120A
(en)
*
|
1993-12-17 |
1995-05-30 |
Alcon Laboratories, Inc. |
Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
|
|
US5837699A
(en)
|
1994-01-27 |
1998-11-17 |
Schering Corporation |
Use of mometasone furoate for treating upper airway passage diseases
|
|
IL109656A
(en)
|
1994-05-15 |
1998-02-22 |
Chemagis Ltd |
Process for the manufacture of androstane - 17 - carbothioates and androstane - 17 - carbothioates prepared thereby
|
|
GB9410222D0
(en)
|
1994-05-21 |
1994-07-06 |
Glaxo Wellcome Australia Ltd |
Medicaments
|
|
GB9419536D0
(en)
*
|
1994-09-28 |
1994-11-16 |
Glaxo Inc |
Medicaments
|
|
SA95160463B1
(ar)
|
1994-12-22 |
2005-10-04 |
استرا أكتيبولاج |
مساحيق للاستنشاق
|
|
DE19528145A1
(de)
|
1995-08-01 |
1997-02-06 |
Boehringer Ingelheim Kg |
Neue Arzneimittel und ihre Verwendung
|
|
GB9521696D0
(en)
|
1995-10-23 |
1996-01-03 |
Bayer Ag |
Combination of LTD4 receptor antagonists with glucocorticosteriods
|
|
US5707984A
(en)
*
|
1995-12-08 |
1998-01-13 |
G. D. Searle & Co. |
Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
|
|
EP0876392B1
(en)
|
1995-12-29 |
2000-07-05 |
Glaxo Group Limited |
Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives
|
|
US5981517A
(en)
*
|
1996-05-09 |
1999-11-09 |
Soft Drugs, Inc. |
Androstene derivatives
|
|
EP0954318A1
(en)
|
1996-06-04 |
1999-11-10 |
The Procter & Gamble Company |
A nasal spray containing an intranasal steroid and an antihistamine
|
|
GB9622173D0
(en)
|
1996-10-24 |
1996-12-18 |
Glaxo Group Ltd |
Particulate Products
|
|
US5919776A
(en)
*
|
1996-12-20 |
1999-07-06 |
Merck & Co., Inc. |
Substituted aminoquinolines as modulators of chemokine receptor activity
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
PT1003501E
(pt)
|
1997-04-02 |
2005-07-29 |
Brigham & Womens Hospital |
Utilizacao de um agente para reduzir o risco de doencas cardiovasculares
|
|
ATE260931T1
(de)
|
1997-06-30 |
2004-03-15 |
Glaxo Group Ltd |
Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
|
|
SE9704186D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
|
SE9704833D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New formulation
|
|
US5972920A
(en)
*
|
1998-02-12 |
1999-10-26 |
Dermalogix Partners, Inc. |
Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
|
|
US6136294C1
(en)
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
|
US6261539B1
(en)
|
1998-12-10 |
2001-07-17 |
Akwete Adjei |
Medicinal aerosol formulation
|
|
GB9828721D0
(en)
|
1998-12-24 |
1999-02-17 |
Glaxo Group Ltd |
Novel apparatus and process
|
|
AU3411000A
(en)
|
1999-03-24 |
2000-10-09 |
Glenayre Electronics, Inc |
Computation and quantization of voiced excitation pulse shapes in linear predictive coding of speech
|
|
US6395300B1
(en)
*
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
WO2001015744A1
(en)
|
1999-08-31 |
2001-03-08 |
The Brigham And Women's Hospital, Inc. |
Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases
|
|
US7413536B1
(en)
|
1999-09-14 |
2008-08-19 |
Xenoport, Inc. |
Substrates and screening methods for transport proteins
|
|
US6596261B1
(en)
|
2000-01-25 |
2003-07-22 |
Aeropharm Technology Incorporated |
Method of administering a medicinal aerosol formulation
|
|
US20020133032A1
(en)
|
2000-02-25 |
2002-09-19 |
Jufang Barkalow |
Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
|
|
DE10017791A1
(de)
|
2000-04-10 |
2001-10-11 |
Basf Ag |
Verfahren und Vorrichtung zur Mikrodosierung kleinster Flüssigkeitsmengen für Biopolymerarrays
|
|
GB0009592D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory combinations
|
|
GB0009583D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory formulations
|
|
GB0009606D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Therapeutic combinations
|
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
|
GB0016040D0
(en)
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
GB0017988D0
(en)
|
2000-07-21 |
2000-09-13 |
Glaxo Group Ltd |
Novel process
|
|
CA2412376A1
(en)
|
2000-07-26 |
2002-01-31 |
Onkar N. Singh |
Pharmaceutical suspension compositions lacking a polymeric suspending agent
|
|
SK287576B6
(sk)
|
2000-08-05 |
2011-03-04 |
Glaxo Group Limited |
S-fluórmetylester kyseliny 6alfa, 9alfa-difluór-17alfa-[(2- furanylkarboxyl)oxy]-11beta-hydroxy-16alfa-metyl-3-oxo-androsta- 1,4-dién-17beta-karbotiovej, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom, jeho použitie a medziprodukty
|
|
GB0020089D0
(en)
|
2000-08-15 |
2000-10-04 |
Smithkline Beecham Biolog |
Vaccine Composition
|
|
IL155092A0
(en)
|
2000-09-29 |
2003-10-31 |
Glaxo Group Ltd |
Compounds useful in the treatment of inflammatory diseases
|
|
US20020132803A1
(en)
|
2001-01-05 |
2002-09-19 |
Mahendra Dedhiya |
Fluticasone suspension formulation, spray pattern method, and nasal spray apparatus
|
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
|
WO2002070490A1
(en)
|
2001-03-08 |
2002-09-12 |
Glaxo Group Limited |
Agonists of beta-adrenoceptors
|
|
WO2002076933A1
(en)
|
2001-03-22 |
2002-10-03 |
Glaxo Group Limited |
Formailide derivatives as beta2-adrenoreceptor agonists
|
|
AU2002303425A1
(en)
|
2001-04-24 |
2002-11-05 |
Epigenesis Pharmaceuticals, Inc. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|